logo

For the Inventor, By the Inventor

Ogden, UT, United States of America

Robert B Wardle

This inventor holds 14 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Alliant Techsystems Inc., Epicentrx, Inc., Orbital Atk, Inc.. Active years: 2002-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert B Wardle. Retrieved from https://idiyas.com/inventor/robert-b-wardle-ccydu5oe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 9

Forward Citations = 173(Granted Patents)


Location History:

  • Ogden, UT (US) (2009 - 2015)
  • Logan, UT (US) (2002 - 2018)

Company Filing History:

goldMedal11 out of 492 
 
Alliant Techsystems Inc.
 patents
silverMedal3 out of 29 
 
Epicentrx, Inc.
 patents
bronzeMedal3 out of 87 
 
Orbital Atk, Inc.
 patents
4. 3 out of 3 
 
Radiorx, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2002-2018

Loading Chart...
Areas of Expertise:
Cyclic Nitro Compounds
Pharmaceutical Compositions
O-Nitro Compounds
Acyclic Organonitro Compounds
Cancer Treatment
Energetic Thermoplastic Elastomers
Polycyclic Polyamides
Synthesis Methods
High Energy Compositions
Thermoplastic Block Polymers
Hexanitro Compounds
Polynitramine Oxidizers
14 patents (USPTO):Explore Patents
1. 10149832 - Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof (2018-12-11),
2. 9226915 - Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof (2016-01-05),
3. 9133150 - O-nitro compounds and pharmaceutical compositions including same (2015-09-15),
4. 8927527 - Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof (2015-01-06),
5. 8664247 - Acyclic organonitro compounds for use in treating cancer (2014-03-04),
6. 8530681 - Pharmaceutical compositions of O-nitro compounds (2013-09-10),
7. 8299053 - Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof (2012-10-30),
8. 8178698 - Methods of synthesizing cyclic nitro compounds (2012-05-15),
9. 7745643 - Methods of synthesizing cyclic nitro compounds (2010-06-29),
10. 7507842 - Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof (2009-03-24),
11. 7129348 - Polycyclic, polyamides as precursors for energetic polycyclic polynitramine oxidizers (2006-10-31),
12. 7101955 - Synthesis of energetic thermoplastic elastomers containing both polyoxirane and polyoxetane blocks (2006-09-05),
13. 6391130 - Process for making 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane (2002-05-21),
14. 6350330 - Poly(butadiene)poly(lactone) thermoplastic block polymers, methods of making, and uncured high energy compositions containing same as binders (2002-02-26),

Title: The Innovative Journey of Robert B. Wardle

Introduction

Robert B. Wardle, a prominent inventor based in Ogden, UT, is known for his significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 14 patents, his innovations focus primarily on cyclic nitro compounds and their applications in treating various health disorders.

Latest Patents

Among his latest patents, the invention titled "Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof and Uses Thereof" stands out. This patent describes a novel cyclic nitro compound combined with pharmaceutical compositions designed for therapeutic applications. Specifically, these compounds target diseases characterized by abnormal cell proliferation, including cancer, inflammation, cardiovascular diseases, and autoimmune disorders. This groundbreaking work opens up new avenues for treatment and prevention, showcasing the potential of cyclic nitro compounds in modern medicine.

Career Highlights

Robert B. Wardle has garnered extensive experience throughout his career, working for reputable companies such as Alliant Techsystems Inc. and Radiorx, Inc. His contributions in these organizations underline his commitment to advancing pharmaceutical technologies and driving innovation.

Collaborations

Throughout his professional journey, Robert has collaborated with notable colleagues including Louis F. Cannizzo and Kirstin F. Warner. These partnerships have played a crucial role in refining his inventions and expanding the impact of his work in the pharmaceutical industry.

Conclusion

In conclusion, Robert B. Wardle's dedication to innovation in the field of cyclic nitro compounds reflects not only his ingenuity as an inventor but also his commitment to improving human health. With a robust portfolio of patents and impactful collaborations, he continues to influence the advancement of medical treatments, making a significant mark in the world of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…